8-K filed January 20, 2022, 6:59 PM ET ticker HIMS CIK 0001773751

leadership confidence high sentiment neutral materiality 0.60

Hims & Hers appoints new CFO Oluyemi Okupe, adds Dr. Patrick Carroll to board

Hims & Hers Health, Inc.

Appointed Oluyemi Okupe as CFO effective Jan 24, 2022; previously CFO of Hipcamp, divisional CFO at Uber and Braintree.
Okupe receives $450K base salary, $350K signing bonus (conditional on 180 days service), and $7M equity grant (40% options, 60% RSUs).
Board expanded to 10 directors; Dr. Patrick Carroll (former CMO) appointed director effective Feb 1, 2022.
Dr. Carroll resigned as Chief Medical Officer effective Jan 31, 2022; will stand for election at 2022 annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

Irene Becklund

Interim Chief Financial Officer

HIMS · Hims & Hers Health, Inc.

Effective: 2022-01-24
Successor: Oluyemi Okupe
Filed: January 20, 2022, 6:59 PM ET

Irene Becklund, the Company’s controller, who is serving as interim principal financial officer and principal accounting officer as disclosed in the Company’s Current Report on Form 8-K filed on November 18, 2021, will continue as the Company’s principal accounting officer but will cease serving as interim principal financial officer upon the effectiveness of Mr. Okupe’s appointment.

Appointed

Oluyemi Okupe

Chief Financial Officer and Principal Financial Officer

HIMS · Hims & Hers Health, Inc.

Effective: 2022-01-24
Filed: January 20, 2022, 6:59 PM ET

On January 18, 2022, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) appointed Oluyemi Okupe as chief financial officer and principal financial officer of the Company, effective January 24, 2022.

Appointed

Patrick Carroll

Director

HIMS · Hims & Hers Health, Inc.

Filed: January 20, 2022, 6:59 PM ET

appointed Dr. Patrick Carroll, M.D., 63

Departed

Patrick Carroll

Chief Medical Officer

HIMS · Hims & Hers Health, Inc.

Filed: January 20, 2022, 6:59 PM ET

Resignation of Chief Medical Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Irene Becklund changed role as Interim Chief Financial Officer at Hims & Hers Health, Inc..

Action: ceased serving as interim principal financial officer
Role: Interim Chief Financial Officer

Exact text from the filing

Irene Becklund, the Company’s controller, who is serving as interim principal financial officer and principal accounting officer as disclosed in the Company’s Current Report on Form 8-K filed on November 18, 2021, will continue as the Company’s principal accounting officer but will cease serving as interim principal financial officer upon the effectiveness of Mr. Okupe’s appointment.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Oluyemi Okupe was appointed as Chief Financial Officer and Principal Financial Officer at Hims & Hers Health, Inc..

Action: appointed
Role: Chief Financial Officer and Principal Financial Officer

Exact text from the filing

On January 18, 2022, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) appointed Oluyemi Okupe as chief financial officer and principal financial officer of the Company, effective January 24, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.65

Patrick Carroll was appointed as Director at Hims & Hers Health, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Dr. Patrick Carroll, M.D., 63

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.6

Patrick Carroll resigned as Chief Medical Officer at Hims & Hers Health, Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

Resignation of Chief Medical Officer

View on SEC.gov

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.